|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,062.12 |
3.25% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$65,896.35 |
3.06% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$54,362.33 |
2.52% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$53,669.34 |
2.49% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$50,850.00 |
2.36% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$49,755.00 |
2.31% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$48,021.71 |
2.23% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$47,100.56 |
2.19% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$47,022.72 |
2.18% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$46,490.03 |
2.16% |
| Waters Corporation |
WAT |
941848103 |
120 |
$46,484.40 |
2.16% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$45,943.50 |
2.13% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$45,680.45 |
2.12% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,464.65 |
2.11% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$45,528.80 |
2.11% |
| Steris Plc |
STE |
G8473T100 |
169 |
$45,401.85 |
2.11% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$45,279.53 |
2.10% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$44,321.54 |
2.06% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,163.22 |
2.05% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,962.05 |
2.04% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$43,198.87 |
2.01% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$43,218.33 |
2.01% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$43,187.89 |
2.00% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$42,558.48 |
1.98% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$42,013.02 |
1.95% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$41,873.82 |
1.94% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$41,566.55 |
1.93% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$40,846.17 |
1.90% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$40,774.88 |
1.89% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$40,793.40 |
1.89% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$40,445.68 |
1.88% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$39,884.56 |
1.85% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,652.02 |
1.84% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$39,488.08 |
1.83% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$39,205.80 |
1.82% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$39,154.89 |
1.82% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$38,592.15 |
1.79% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,864.26 |
1.76% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,425.98 |
1.74% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$36,897.20 |
1.71% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$36,813.26 |
1.71% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$36,830.72 |
1.71% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$36,757.51 |
1.71% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$36,649.76 |
1.70% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$36,539.87 |
1.70% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$36,537.90 |
1.70% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$36,402.42 |
1.69% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$34,402.00 |
1.60% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$34,267.44 |
1.59% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$32,109.27 |
1.49% |
| US Dollar |
$USD |
|
2,704 |
$2,704.37 |
0.13% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|